title: Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases.
authors: Biocompatibles UK Ltd, Farnham, Surrey, United Kingdom. yiqing.tang@biocompatibles.com <yiqing.tang@biocompatibles.com>
authors: Y
authors: Y
authors: Tang
authors: R R
authors: RR
authors: Taylor
authors: M V
authors: MV
authors: Gonzalez
authors: A L
authors: AL
authors: Lewis
authors: P W
authors: PW
authors: Stratford
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D016503:Drug Delivery Systems / Q000379:methods*; D006499:Hepatic Artery; D007261:Infusions, Intra-Arterial; D000077146:Irinotecan; D008113:Liver Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000556:secondary; D013552:Swine
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D002166:Camptothecin